53 research outputs found
Building an Effective Biosafety Regulatory System: The Nuts and Bolts
Abstract Activities with genetically modified organisms (GMOs) are subject to regulation in most countries. Nevertheless, many low income countries are in the early stages of establishing or implementing biosafety regulation. Whereas the importance of risk assessment in regulatory decision-making is well recognised and supported by guidance material and training courses, little guidance is available for other components that are necessary for a functional regulatory system. This review describes the key components common to most well-established regulatory systems and also provides some consideration on streamlining the structure and procedures for each component. It also describes some simple, commonly used tools, with examples, that may assist in the design and/or function of these regulatory components. Integrating these key components and applying the various regulatory tools can provide the basis for establishing an efficient and effective regulatory system for low income countries. Keywords: biosafety, decision-making, genetically modified organisms, regulatory system, tools. Riassunto Le attività con gli organismi geneticamente modificati (OGM) sono soggette a regolamentazione nella maggior parte dei Paesi. Tuttavia, molti Paesi a basso reddito sono ancora nelle prime fasi di creazione o di attuazione delle norme sulla biosicurezza. Nel processo decisionale normativo l'importanza della valutazione del rischio è ben nota e supportata da materiale di orientamento e corsi di formazione, poche sono invece le indicazioni disponibili sugli altri componenti necessari per un valido sistema di regolamentazione. Questo articolo descrive componenti chiave che sono comuni nella maggior parte dei sistemi normativi più consolidati, e fornisce qualche considerazione sulla razionalizzazione della struttura e sulle procedure di ogni componente. Esso descrive inoltre alcuni semplici strumenti di uso comune, con esempi che possono aiutare nella progettazione e/o funzionamento di tali componenti, la cui integrazione insieme all'applicazione dei diversi strumenti normativi, può fornire la base per la creazione di un sistema normativo efficiente ed efficace per i Paesi a basso reddito
Genetic basis and detection of unintended effects in genetically modified crop plants
In January 2014, an international meeting sponsored by the International Life Sciences Institute/Health and Environmental Sciences Institute and the Canadian Food Inspection Agency titled “Genetic Basis of Unintended Effects in Modified Plants” was held in Ottawa, Canada, bringing together over 75 scientists from academia, government, and the agro-biotech industry. The objectives of the meeting were to explore current knowledge and identify areas requiring further study on unintended effects in plants and to discuss how this information can inform and improve genetically modified (GM) crop risk assessments. The meeting featured presentations on the molecular basis of plant genome variability in general, unintended changes at the molecular and phenotypic levels, and the development and use of hypothesis-driven evaluations of unintended effects in assessing conventional and GM crops. The development and role of emerging “omics” technologies in the assessment of unintended effects was also discussed. Several themes recurred in a number of talks; for example, a common observation was that no system for genetic modification, including conventional methods of plant breeding, is without unintended effects. Another common observation was that “unintended” does not necessarily mean “harmful”. This paper summarizes key points from the information presented at the meeting to provide readers with current viewpoints on these topics
Problem formulation in the environmental risk assessment for genetically modified plants
Problem formulation is the first step in environmental risk assessment (ERA) where policy goals, scope, assessment endpoints, and methodology are distilled to an explicitly stated problem and approach for analysis. The consistency and utility of ERAs for genetically modified (GM) plants can be improved through rigorous problem formulation (PF), producing an analysis plan that describes relevant exposure scenarios and the potential consequences of these scenarios. A properly executed PF assures the relevance of ERA outcomes for decision-making. Adopting a harmonized approach to problem formulation should bring about greater uniformity in the ERA process for GM plants among regulatory regimes globally. This paper is the product of an international expert group convened by the International Life Sciences Institute (ILSI) Research Foundation
The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients
Genomics and proteomics will improve outcome prediction in cancer and have great potential to help in the discovery of unknown mechanisms of metastasis, ripe for therapeutic exploitation. Current methods of prognosis estimation rely on clinical data, anatomical staging and histopathological features. It is hoped that translational genomic and proteomic research will discriminate more accurately than is possible at present between patients with a good prognosis and those who carry a high risk of recurrence. Rational treatments, targeted to the specific molecular pathways of an individual’s high-risk tumor, are at the core of tailored therapy. The aim of targeted oncology is to select the right patient for the right drug at precisely the right point in their cancer journey. Optical proteomics uses advanced optical imaging technologies to quantify the activity states of and associations between signaling proteins by measuring energy transfer between fluorophores attached to specific proteins. Förster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM) assays are suitable for use in cell line models of cancer, fresh human tissues and formalin-fixed paraffin-embedded tissue (FFPE). In animal models, dynamic deep tissue FLIM/FRET imaging of cancer cells in vivo is now also feasible. Analysis of protein expression and post-translational modifications such as phosphorylation and ubiquitination can be performed in cell lines and are remarkably efficiently in cancer tissue samples using tissue microarrays (TMAs). FRET assays can be performed to quantify protein-protein interactions within FFPE tissue, far beyond the spatial resolution conventionally associated with light or confocal laser microscopy. Multivariate optical parameters can be correlated with disease relapse for individual patients. FRET-FLIM assays allow rapid screening of target modifiers using high content drug screens. Specific protein-protein interactions conferring a poor prognosis identified by high content tissue screening will be perturbed with targeted therapeutics. Future targeted drugs will be identified using high content/throughput drug screens that are based on multivariate proteomic assays. Response to therapy at a molecular level can be monitored using these assays while the patient receives treatment: utilizing re-biopsy tumor tissue samples in the neoadjuvant setting or by examining surrogate tissues. These technologies will prove to be both prognostic of risk for individuals when applied to tumor tissue at first diagnosis and predictive of response to specifically selected targeted anticancer drugs. Advanced optical assays have great potential to be translated into real-life benefit for cancer patients
African Linguistics in Central and Eastern Europe, and in the Nordic Countries
Non peer reviewe
Structures of viroids and virusoids and their functional significance
Includes bibliographical references108 leaves, [15] leaves of plates : ill. (some col.) ; 30 cm.Thesis (Ph.D.)--University of Adelaide, Dept. of Biochemistry, 198
Putative full-length clones of the genomic DNA segments of subterranean clover stunt virus and identification of the segment coding for the viral coat protein
Subterranean clover stunt disease is an economically important aphid-borne virus disease affecting certain pasture and grain legumes in Australia. The virus associated with the disease, subterranean clover stunt virus (SCSV), was previously found to be representative of a new type of single-stranded DNA virus. Analysis of the virion DNA and restriction mapping of double-stranded cDNA synthesized from virion DNA suggested that SCSV has a segmented genome composed of 3 or 4 different species of circular ssDNA each of about 850-880 nucleotides. To further investigate the complexity of the SCSV genome, we have isolated the replicative form DNA from infected pea and from it prepared putative full-length clones representing the SCSV genome segments. Analysis of these clones by restriction mapping indicated that clones representing at least 4 distinct genomic segments were obtained. This method is thus suitable for generating an extensive genomic library of novel ssDNA viruses containing multiple genome segments such as SCSV and banana bunchy top virus. The N-terminal amino acid sequence and amino acid composition of the coat protein of SCSV were determined. Comparison of the amino acid sequence with partial DNA sequence data, and the distinctly different restriction maps obtained for the full-length clones suggested that only one of these clones contained the coat protein gene. The results confirmed that SCSV has a functionally divided genome composed of several distinct ssDNA circles each of about 1 kb
- …